We Can Do Better: Improving Care for Women Over Age 50
- Translate recent guidelines on hormone replacement therapy into clinical practice.
- Provide sensitive, informed care about common sexual issues in peri- and post-menopausal women.
- Counsel appropriately about important lifestyle issues in post-menopausal women.
UNLABELED USE DISCLOSURE:
This activity will not include discussions of products or devices that are not currently approved for use by the Food and Drug Administration (FDA), and the curriculum clearly indicates this fact.
This activity is designed for family physicians, primary care physicians, nurses, nurse practitioners, and other team members who are interested in providing high quality health care to women over 50.
PARTICIPATION AND CREDIT:
Learners must register to participate in and receive credit for this online educational activity. Read the target audience, learning objectives, and author disclosures. Study the educational content online and choose the best answers to each question. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
CAFP policy and California state law requires that each learning activity have elements of cultural and linguistic proficiency included in the content. This activity includes these elements.
The California Academy of Family Physicians (CAFP) is committed to protecting the privacy of its members and customers. CAFP maintains safeguards to store and secure information it has about members and customers. The safeguards may be physical, electronic or procedural. For more information, go to https://www.familydocs.org/
For questions regarding the content of this activity or for technical assistance, contact email@example.com.
The CAFP has made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education program. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the learner is advised to check the manufacturer's package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Approval of credit for this continuing education program does not imply endorsement by CAFP of any product or manufacturer identified.
Any medications or treatment methods suggested in this CME activity should not be used by the practitioner without evaluation of their patient's condition(s) and possible contraindication(s) or danger(s) of use of any specific medication.
- The Writing Group for the WHI Investigators. Risks and benefits of estrogen plus progestin in healthy post-menopausal women: Principal results of the Women's Health Initiative randomized controlled trial. JAMA 2002;288(3):321-333.
- The Women's Health Initiative Steering Committee. Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy. The Women's Health Initiative Randomized Controlled Trial. JAMA 2004;291:1701-1712.
- Menopause: The Journal of the North American Menopause Society, Vol 19, No 3, pp 257-271, 2012
- JAMA. 2017;318(22):2234-2249. doi:10.1001/jama.2017.16952
- Menopause: The Journal of the North American Menopause Society; Vol 24, No 7, pp 728-753; 2017
- Jack S. Annon (1976) The PLISSIT Model: A Proposed Conceptual Scheme for the Behavioral Treatment of Sexual Problems, Journal of Sex Education and Therapy, 2:1, 1-15, DOI: 10.1080/01614576.1976.11074483
- Office on Women’s Health.gov citation/reference
Cheri Olson, MD
CONFLICT OF INTEREST STATEMENTS
AAFP PRESCRIBED CREDIT
- 0.50 AAFP Prescribed